Ferinject® Assessment In GastRectomy Patients With Acute Isovolemic Anemia (FAIRY)
Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the efficacy of Ferinject® in improving acute isovolemic
anemia after gastrectomy for gastric cancer in terms of Quality of life(QOL )and objective
measures (Hb and iron parameters).
Furthermore, the tolerability and safety of Ferinject® treatment will be evaluated.